These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21210170)

  • 1. Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated.
    Jurevic RJ; Traboulsi RS; Mukherjee PK; Salata RA; Ghannoum MA;
    Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):629-33. PubMed ID: 21210170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
    Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
    AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentian violet in the treatment of oral candidiasis.
    Leung AK
    Pediatr Infect Dis J; 1988 Apr; 7(4):304-5. PubMed ID: 3368270
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet.
    Wright SC; Maree JE; Sibanyoni M
    Phytomedicine; 2009 Mar; 16(2-3):118-24. PubMed ID: 19109001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
    Traboulsi RS; Mukherjee PK; Ghannoum MA
    Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of subinhibitory concentrations of gentian violet on the germ tube formation by Candida albicans and its adherence to oral epithelial cells.
    Mafojane T; Shangase SL; Patel M
    Arch Oral Biol; 2017 Oct; 82():1-5. PubMed ID: 28575640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial.
    Chayachinda C; Thamkhantho M; Ngamsakulrungroj P; Leeyaphan C; Tulyaprawat O
    J Obstet Gynaecol; 2022 Aug; 42(6):2190-2196. PubMed ID: 35253598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to Candida and oral mycotic infections: Workshop 2A.
    McCullough M; Patton LL; Coogan M; Fidel PL; Komesu M; Ghannoum M; Leigh JE
    Adv Dent Res; 2011 Apr; 23(1):152-8. PubMed ID: 21441497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Worst Thrush I Have Ever Seen.
    Douvoyiannis M; Swank C
    Pediatr Emerg Care; 2016 Sep; 32(9):614-5. PubMed ID: 27248773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antifungal activities of gentian violet and povidone-iodine against clinical isolates of Candida species and other yeasts: a framework to establish topical disinfectant activities.
    Kondo S; Tabe Y; Yamada T; Misawa S; Oguri T; Ohsaka A; Miida T
    Mycopathologia; 2012 Jan; 173(1):21-5. PubMed ID: 21837508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More on thrush and the use of gentian violet.
    Wilson-Clay B
    J Hum Lact; 1991 Jun; 7(2):58. PubMed ID: 1822987
    [No Abstract]   [Full Text] [Related]  

  • 12. Obstructive laryngotracheitis secondary to gentian violet exposure.
    Baca D; Drexler C; Cullen E
    Clin Pediatr (Phila); 2001 Apr; 40(4):233-5. PubMed ID: 11336425
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
    Su CW; Gaskie S; Jamieson B; Triezenberg D
    J Fam Pract; 2008 Jul; 57(7):484-5. PubMed ID: 18625176
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients.
    Patel M; Shackleton JA; Coogan MM; Galpin J
    AIDS Patient Care STDS; 2008 Aug; 22(8):613-8. PubMed ID: 18627277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
    Nyst MJ; Perriens JH; Kimputu L; Lumbila M; Nelson AM; Piot P
    Ann Soc Belg Med Trop; 1992 Mar; 72(1):45-52. PubMed ID: 1567268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orabase-formulated gentian violet effectively improved oral potentially malignant disorder in vitro and in vivo.
    Wang YY; Xiao LY; Wu PC; Chen YK; Lo S; Hu SCS; Chen YH; Chiu CCC; Yuan SSF
    Biochem Pharmacol; 2020 Jan; 171():113713. PubMed ID: 31733192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and pharyngeal candidiasis. Topical agents for management and prevention.
    Epstein JB
    Postgrad Med; 1989 Apr; 85(5):257-8, 263-5, 268-9. PubMed ID: 2648372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment of gentian violet anti- candida activity.
    Gomes-de-Elvas AR; Palmeira-de-Oliveira A; Gaspar C; Gouveia P; Palmeira-de-Oliveira R; Pina-Vaz C; Rodrigues AG; Martinez-de-Oliveira J
    Gynecol Obstet Invest; 2012; 74(2):120-4. PubMed ID: 22889741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentian violet: a 19th century drug re-emerges in the 21st century.
    Maley AM; Arbiser JL
    Exp Dermatol; 2013 Dec; 22(12):775-80. PubMed ID: 24118276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.